Overman, M. J., Morris, V., Kee, B., Fogelman, D., Xiao, L., Eng, C., . . . Kopetz, S. (2016). Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials(†). Ann Oncol.
Chicago-stil citatOverman, M. J., et al. "Utility of a Molecular Prescreening Program in Advanced Colorectal Cancer For enrollment On Biomarker-selected Clinical Trials(†)." Ann Oncol 2016.
MLA-referensOverman, M. J., et al. "Utility of a Molecular Prescreening Program in Advanced Colorectal Cancer For enrollment On Biomarker-selected Clinical Trials(†)." Ann Oncol 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.